Biotage AB (publ) publishes its 2020 Annual Report, Corporate Governance Report and Remuneration Report

Rhea-AI Summary

Biotage AB has released its 2020 Annual Report, Corporate Governance Report, and Remuneration Report. The reports are now available for download at www.biotage.com. The company reported sales of 1,092 MSEK in 2020 and operates globally, serving various sectors including pharmaceuticals, biotech, and environmental testing. Biotage aims to contribute to sustainable science and is listed in the Mid Cap segment on NASDAQ Stockholm under the symbol BITGY.

Positive

• Sales of 1,092 MSEK in 2020.
• Global operations with products available in over 70 countries.
• Focus on sustainable science and environmental testing.

Negative

• None.

UPPSALA, Sweden, March 26, 2021 /PRNewswire/ -- Biotage's 2020 Annual Report, Corporate Governance Report and Remuneration Report are as of today available at: www.biotage.com

This is information that Biotage AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 17.00 CET on March 26, 2021.

Contact persons:
Tomas Blomquist, CEO
Tel: 0705 23 01 63, tomas.blomquist@biotage.com

Biotage AB
Box 8
SE-751 03 Uppsala
Tel:018 56 59 00 
www.biotage.com

About Biotage
solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner - HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of 1,092 MSEK in 2020 and our products are sold in more than 70 countries. Biotage's share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/biotage/r/biotage-ab--publ--publishes-its-2020-annual-report--corporate-governance-report-and-remuneration-rep,c3315306

The following files are available for download:

https://mb.cision.com/Main/705/3315306/1393529.pdf

The full report in Swedish (PDF)

View original content:http://www.prnewswire.com/news-releases/biotage-ab-publ-publishes-its-2020-annual-report-corporate-governance-report-and-remuneration-report-301256834.html

SOURCE Biotage

FAQ

What is the significance of Biotage's 2020 Annual Report?

The report includes key financial metrics, highlighting sales of 1,092 MSEK and insights into corporate governance.

When was Biotage's 2020 Annual Report published?

The report was published on March 26, 2021.

Where can I find Biotage's 2020 Annual Report?

The report is available for download at www.biotage.com.

What are Biotage's main market segments?

Biotage serves pharmaceutical, biotech, and environmental testing sectors.

Is Biotage listed on a stock exchange?

Yes, Biotage is listed on the NASDAQ Stockholm under the symbol BITGY.